Skip to search formSkip to main contentSkip to account menu

MK 0966

Known as: MK 966, MK-0966, MK-966 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

rofecoxib

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
PAF & Arachidonic Acid Cascade
The aim of the study was to examine the activity of neutrophils taken from synovial fluid of patients with rheumatoid arthritis… 
2001
2001
Rofecoxib,MK-0966
Deutschland: - Ȕsterreich: - Schweiz: Rp. B; Schwangerschaftskategorie C (Trimenon I,II) und D (Trimenon III… 
2000
2000
Role of COX‐1‐ and COX‐2‐synthesized prostaglandins in a rat model of arthritic pain
An appropriate animal model for investigation of antiinflammatory analgesic effects of NSAIDs is the pain‐induced functional… 
2000
2000
Determination of rofecoxib (MK-0966), a cyclooxygenase-2 inhibitor, in human plasma by high-performance liquid chromatography with tandem mass spectrometric detection.
Review
1999
Review
1999
The Cyclooxygenase-2 Inhibitors: Safety and Effectiveness
OBJECTIVE: To review the development of cyclooxygenase-2 (COX-2) inhibitors and discuss specific agents that are currently under… 
1999
1999
Influence of Antacids on The Bioavailability (F) of A Specific Cyclooxygenase (COX)‐2 Inhibitor, MK‐0966 (M) in The Elderly
1999
1999
Effect of age on renal responses to COX-2 inhibitors, rofecoxib (VIOXX™, MK-0966), celecoxib and meloxicam, in conscious dogs.
1999
1999
MK‐0966, a cyclooxygenase‐2 (COX‐2) specific inhibitor, had no effect on the anti‐platelet activity of low‐dose aspirin (ASA) measured by serum thromboxane B2 (TXB2) production and platelet…
1998
1998
Influence of the selective cyclooxygenase-2 inhibitor, MK-0966 [MK], on digoxin [DG] serum concentrations
1997
1997
New Strategies Yield Optimism for Arthritis
An assortment of drugs that slow arthritis progression and ease its symptoms could reach patients by the year 2000. The new… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)